This paper is only available as a PDF. To read, Please Download here.
To examine the potential role of lipoxygenase products in the pathophysiology observed after experimental tumor implantation, we examined the generation of leukotrienes (LTs) and hydroxyeicosatetraenoic acids (HETEs) in peritoneal macrophages. mice were given subcutaneous inoculations of B16 melanoma cells, and peritoneal macrophages were isolated various days after the inoculation. Macrophages were incubated for 1 h at 37°C in serum-free RPMI1640 containing 10 μM calcium ionophore A23187, 10 μM exogenous arachidonic acid (AA), 5 mM cysteine hydrochloride and 1 mM reduced glutathione. LTs and HETEs were separately extracted, passed through Sep-Pak cartridges, then identified and quantitated with a HPLC system using UV absorbance. The B16 melanoma-cell-treated/untreated macrophages were found to produced substantial amounts of 15-HETE, 12-HETE and 5-HETE and LTC4 by enzymatic mechanisms. Thus, when determined under various conditions, the production of HETEs was dependent on substrate-concentration, incubation-time and cell-number. The production of LTC4 was dependent on incubation-time and cell number but not substrate-concentration, indicating utilization of endogenous AA stores. Of these products, 12-HETE and LTC4 showed a significant increase on the fourth day after the tumor cell inoculation and returned to the control level by the 11th day after the same treatment. These results suggest that in vivo tumor cell implantation may induce a transient increase of 12-HETE and LTC4 production in macrophages.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Regulation of prostaglandin synthesis during differentiation of cultured mouse myeloid leukemia cells.J. Cell Physiol. 1980; 104: 349-357
- Inhibition of differentiation of cultured mouse myeloid leukemia cells by nonsteroidal antiinflammatory agents and counteraction of the inhibition by prostaglandin E1.Cancer Res. 1979; 39: 2190-2194
- Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.J. Exp. Med. 1977; 146: 1719-1734
- The effects of prostaglandins on the proliferation of cultured human T lymphocytes.Immunopharmacol. 1983; 6: 267-277
- The mechanisms of inhibition of human IL 2 production. PG22 induction of suppressor T lymphocytes.J. Immunol. 1984; 132: 1851-1857
- Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U937.Biochim Biophys Acta. 1990; 1042: 395-403
- Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions.J. Clinical Oncology. 1984; 2: 937-943
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1.Nature. 1986; 323: 86-89
- Differential effects of docosahexaenoic acid and eicosapentaenoic acid on suppression of lipoxygenase pathway in peritoneal macrophages.Biochim. Biophys. Acta. 1988; 958: 99-107
- Isolation and identification of lipoxygenase products from the rat central nervous system.Biochim. Biophys. Acta. 1987; 922: 372-378
- Increased prostaglandin synthesis by macrophages from tumor-bearing mice.J. Immunol. 1979; 123: 2118-2125
- Amplification by macrophages of prostaglandin-mediated immunosuppression in mice bearing syngeneic tumors.Prostaglandins, Leukotrienes and Medicine. 1984; 16: 205-223
- Prostaglandins, macrophages, and immunity.J. Immunol. 1980; 125: 1-5
- Eicosanoid synthesis of alveolar macrophages in rats with malignant mammary tumors: Differences in rats treated with and without carrageenan implants.Prostaglandins Leukotrienes and Essential Fatty Acids. 1989; 37: 113-120
- The formation of thromboxane B2, leukotriene B4 and 12-hydroxyeicosatetraenoic acid by alveolar macrophages after activation during tumor growth in the rat.Biochim. Biophys. Acta. 1990; 1042: 255-258
- Leukotrienes, positive signals for regulation of interferon-γ production.J Immunol. 1984; 132: 413-416
- Differential effects of Leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions.J Immunol. 1985; 135: 1357-1360
- Leukotrienes augment interleukin production by human monocytes.J Immunol. 1985; 135: 3958-3961
- The role of arachidonic acid metabolism in the activities of interleukin 1 and 2.J Immunol. 1986; 135: 1153-1159
- Identification of interferon-γ as the lymphokine that mediates leukotriene B4-induced immunoregulation.J Immunol. 1987; 139: 513-517
- Leukotrienes and macrophage activation: Augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production.Agents and Actions. 1989; 26: 141-147
- Leukotriene C4 is an essential 5-lipoxygenase intermediate in A23187-induced macrophage cytostatic activity against P815 tumor cells.Prostaglandins Leukotrienes and Essential Fatty Acids. 1990; 39: 283-290
- Specific lipoxygenase inhibition reverses macrophage cytostasis towards P815 tumor cells in vitro induced by the calcium ionophore A23187.Prostaglandins Leukotrienes and Essential Fatty Acids. 1988; 34: 187-192
- Role of lipoxygenaton in human natural killer cell activation.J. Immunol. 1986; 136: 1783-1790
Accepted: July 3, 1991
Received: May 18, 1991
© 1991 Published by Elsevier Inc.